The amended deal between the two cannabis companies is a doozy.
I continue to recommend a reduced long exposure on STZ.
Publicly traded cannabis companies are expected to take big write downs on assets, and here's why it matters.
Let's review the charts and indicators ahead of earnings.
As psychedelic medicines begin to become decriminalized, psilocybin seems to be leading the way in this category.
Fresh off IPO, company sees mushrooming opportunity in psilocybin.
There are huge problems now plaguing the industry, which was just beginning to recover from last year's oversupply issues.
TCNNF is a 'seed-to-sale' company that offers 155 products.
Only five companies went public during the first half of 2020 versus 13 in the first half of 2019.
Following widely reported lung injuries and bans, the products struggle to come back as concerns over Covid-19 burn on.